Yi Hsiu Chen

US Patent:

6657675, Dec 2, 2003

Filed:

Apr 13, 2000

Appl. No.:

09/548926

Inventors:

Cheen Doung - Cupertino CA
Lei He - Santa Clara CA
Yi Chen - San Jose CA
Hong Min Zhang - Santa Clara CA

Assignee:

NDSP Corporation - Campbell CA

International Classification:

H04N 1120

US Classification:

348449, 348441, 348604

Abstract:

Non-standard broadcast television signals are processed and converted for proper reception and display. Extra or missing horizontal lines are processed using modulo or digital phase lock loop-type circuit to change clock output signal proportionately according to a difference determined by comparing a standard video signal value with an actual input signal line count value, such that modified clock output signal serves as a clock input signal for circuit accepting standard video format. Non-standard video signal having improper odd-even field sequencing is also processed and converted.

US Patent:

7386888, Jun 10, 2008

Filed:

Oct 9, 2003

Appl. No.:

10/683873

Inventors:

Yung Chang Liang - Cupertino CA, US
Yi Fen Chen - Pasadena CA, US

Assignee:

Trend Micro, Inc.

International Classification:

G06F 11/00
G06F 12/14
G06F 12/16
G06F 15/18
G08B 23/00

US Classification:

726 23, 726 22, 726 24, 726 25, 713188

Abstract:

In a distributed network having a number of server computers and associated client devices, method of isolating infected client devices from uninfected client devices is described. The method is carried out by correlating network related virus infection information, determining if a virus outbreak has occurred based on the correlated information, isolating infected client devices from uninfected client devices when the virus outbreak is confirmed, monitoring all data packets in the network for the virus, identifying a packet type associated with the virus, and blocking only the identified packet type.

US Patent:

7523493, Apr 21, 2009

Filed:

Oct 9, 2003

Appl. No.:

10/684330

Inventors:

Yung Chang Liang - Cupertino CA, US
Yi Fen Chen - Pasadena CA, US

Assignee:

Trend Micro Incorporated

International Classification:

G06F 15/16
G06F 9/00
G06F 17/00
G06F 12/14
G06F 11/00
G06F 12/16
G06F 15/18

US Classification:

726 13, 726 24, 713188

Abstract:

A network level virus monitoring system capable of monitoring a flow of network traffic in any of a number of inspection modes depending upon the particular needs of a system administrator. The monitoring provides an early warning of a virus attack thereby facilitating quarantine procedures directed at containing a virus outbreak. By providing such an early warning, the network virus monitor reduces the number of computers ultimately affected by the virus attack resulting in a concomitant reduction in both the cost of repair to the system and the amount of downtime. In this way, the inventive network virus monitor provides a great improvement in system uptime and reduction in system losses.

US Patent:

7565550, Jul 21, 2009

Filed:

Oct 9, 2003

Appl. No.:

10/683582

Inventors:

Yung Chang Liang - Cupertino CA, US
Yi Fen Chen - Pasadena CA, US

Assignee:

Trend Micro, Inc.

International Classification:

G06F 11/30
G06F 12/14
H04L 9/32

US Classification:

713188

Abstract:

A network level virus monitoring system capable of monitoring a flow of network traffic in any of a number of inspection modes depending upon the particular needs of a system administrator. The system includes a network virus sensor self registration module coupled to a network virus/worm sensor arranged to automatically self register the associated network virus/worm sensor. The monitoring provides an early warning of a virus attack thereby facilitating quarantine procedures directed at containing a virus outbreak. By providing such an early warning, the network virus monitor reduces the number of computers ultimately affected by the virus attack resulting in a concomitant reduction in both the cost of repair to the system and the amount of downtime. In this way, the inventive network virus monitor provides a great improvement in system uptime and reduction in system losses.

US Patent:

7605079, Oct 20, 2009

Filed:

May 11, 2006

Appl. No.:

11/382799

Inventors:

Erh Kun Lai - Longjing Shaing, TW
Chiahua Ho - Kaohsiung, TW
Yi Chou Chen - Cupertino CA, US
Kuang Yeu Hsieh - Jhubei, TW

Assignee:

Macronix International Co., Ltd. - Hsinchu

International Classification:

H01L 21/44

US Classification:

438666, 438128, 438667, 438652

Abstract:

A method for manufacturing a phase change memory device comprises forming an electrode layer. Electrodes are made in the electrode layer using conductor fill techniques that are also used inter-layer conductors for metallization layers, in order to improve process scaling with shrinking critical dimensions for metallization layers. The electrode layer is made by forming a multi-layer dielectric layer on a substrate, etching the multi-layer dielectric layer to form vias for electrode members contacting circuitry below, forming insulating spacers on the vias, etching through a top layer in the multi-layer dielectric layer to form trenches between the insulating spacers for electrode members contacting circuitry above, filling the vias and trenches with a conductive material using the metallization process. Thin film bridges of memory material are formed over the electrode layer.

US Patent:

7705018, Apr 27, 2010

Filed:

Mar 24, 2008

Appl. No.:

12/079322

Inventors:

Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Garwood NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/47

US Classification:

514314, 544333, 546167

Abstract:

Substituted bicyclic heteroaryls having the general formula.

US Patent:

7919498, Apr 5, 2011

Filed:

Mar 24, 2008

Appl. No.:

12/079281

Inventors:

Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Garwood NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

C07D 487/04
A61K 31/519
A61P 19/02
A61P 29/00

US Classification:

5142621, 544262, 544280, 5142651

Abstract:

Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukemia (AML) Myelodysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

US Patent:

8183258, May 22, 2012

Filed:

Jul 20, 2011

Appl. No.:

13/187135

Inventors:

Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US

Assignee:

Amgen Inc. - Thousand Oaks CA

International Classification:

A61K 31/47

US Classification:

514314

Abstract:

Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.